AF Screening in Patients With Abnormal Echocardiographic Parameters
Recruiting
N/A
Interventional Study
Atrial Fibrillation (AF)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 3,000 (estimated)
- Sponsor
- Tze-Fan Chao · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To evaluate the feasibility of specific echocardiographic parameters as criteria for AF screening and to determine the AF detection yield of scheduled extended ECG monitoring compared to contemporary care.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria: patients who met any of the following criteria
1. LAE: defined as LAD ≥ 45 mm or LAVI \> 34 ml/m2;
2. LVH: defined as LV septal or posterior wall thickness ≥ 15 mm;
3. E/e' \> 14;
4. grade II or III diastolic dysfunction;
5. VHD;
6. HF: defined as LVEF \< 40% or LVEF ≥40% with c…
Contacts